Skip to product information
1 of 1

Elsevier

Diagnostic Pathology: Molecular Oncology

Diagnostic Pathology: Molecular Oncology

Regular price $219.73 USD
Regular price $347.99 USD Sale price $219.73 USD
Sale Sold out
Quantity
View full details

Covering all aspects of molecular pathology as it relates to the transformation and pathogenesis of cancer, this award-winning volume in the Diagnostic Pathology?series is an expert resource for pathologists at all levels of experience and training, both as a quick reference and as an efficient review to improve knowledge and skills. This easily accessible, point-of-care reference features templated, bulleted content that is generously illustrated with charts, graphs, tables, and color photomicrographs of histology with special stains. It offers a practical, clinical approach to examining how molecular mutations affect common medical diseases and identifies the relevant and appropriate molecular tests to perform for a complete work-up in the era of molecular-targeted therapies.

  • Provides updated information on molecular mutations in different tumors, including solid tumors and hematopoietic neoplasms, and new targeted therapies geared toward these molecular alterations
  • Discusses now widely used immunotherapy treatments, including how immunotherapy has revolutionized the treatment of many neoplasms such as breast and lung carcinomas and lymphoma
  • Features more than 2,000 annotated images throughout, including H&E stains, immunostains, and FISH images
  • Covers timely topics such as:
    • Recent advances in cancer immunotherapy, specifically in the molecular basis of immunotherapy
    • Newly discovered targeted therapies, including multiple lung carcinoma therapies now considered for patients based on existing mutations to specific genes (KRAS, ALK, BRAF, and ROS)
    • The need for integration of myeloid and lymphoid gene panels due to increased knowledge from next generation sequencing studies of new mutations and the resulting newly developed molecular targets
    • Increased usage of next generation sequencing techniques
    • Changes to hematopoietic tumor details based on revised WHO guidelines

  • Recipient of a 2016 BMA Award: Highly Commended, Pathology (previous edition)
  • Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices

Author: Mohammad A. Vasef,Aaron Auerbach

Publisher: Elsevier
Publish Date: 2019-07-31
Edition: 2
ISBN: 0323611443
ISBN 13: 9780323611442
Dimension: Length: 8.75 inches, Width: 1.75 inches, Height: 11 inches
Weight: Weight: 6.7902376696 pounds
Binding: Hardcover
Pages: 1016

Covering all aspects of molecular pathology as it relates to the transformation and pathogenesis of cancer, this award-winning volume in the Diagnostic Pathology?series is an expert resource for pathologists at all levels of experience and training, both as a quick reference and as an efficient review to improve knowledge and skills. This easily accessible, point-of-care reference features templated, bulleted content that is generously illustrated with charts, graphs, tables, and color photomicrographs of histology with special stains. It offers a practical, clinical approach to examining how molecular mutations affect common medical diseases and identifies the relevant and appropriate molecular tests to perform for a complete work-up in the era of molecular-targeted therapies.

  • Provides updated information on molecular mutations in different tumors, including solid tumors and hematopoietic neoplasms, and new targeted therapies geared toward these molecular alterations
  • Discusses now widely used immunotherapy treatments, including how immunotherapy has revolutionized the treatment of many neoplasms such as breast and lung carcinomas and lymphoma
  • Features more than 2,000 annotated images throughout, including H&E stains, immunostains, and FISH images
  • Covers timely topics such as:
    • Recent advances in cancer immunotherapy, specifically in the molecular basis of immunotherapy
    • Newly discovered targeted therapies, including multiple lung carcinoma therapies now considered for patients based on existing mutations to specific genes (KRAS, ALK, BRAF, and ROS)
    • The need for integration of myeloid and lymphoid gene panels due to increased knowledge from next generation sequencing studies of new mutations and the resulting newly developed molecular targets
    • Increased usage of next generation sequencing techniques
    • Changes to hematopoietic tumor details based on revised WHO guidelines

  • Recipient of a 2016 BMA Award: Highly Commended, Pathology (previous edition)
  • Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices

Author: Mohammad A. Vasef,Aaron Auerbach

Publisher: Elsevier
Publish Date: 2019-07-31
Edition: 2
ISBN: 0323611443
ISBN 13: 9780323611442
Dimension: Length: 8.75 inches, Width: 1.75 inches, Height: 11 inches
Weight: Weight: 6.7902376696 pounds
Binding: Hardcover
Pages: 1016